About the Bateman Lab

Dr. Bateman’s laboratory focuses on the causes, diagnosis, and future treatments of Alzheimer’s disease (AD). We directly measure the pathology and pathophysiology of AD in humans using multiple techniques. Our group uses a wide variety of assays and techniques from the most basic applications, such as quantitative measurement of stable-isotope labeled peptides, to clinical translational studies in diagnostic and therapeutic biomarkers for AD.

Read More >

About Dr. Bateman

Randall J. Bateman, M.D. is the Charles F. and Joanne Knight Distinguished Professor of Neurology at Washington University School of Medicine, Director of the Dominantly Inherited Alzheimer Network (DIAN, http://dian.wustl.edu), and Director of the DIAN Trials Unit (DIAN-TU).

Dr. Bateman’s laboratory investigates the causes and methods of diagnosis and treatment of Alzheimer’s disease (AD) utilizing a wide variety of assays and techniques from basic applications, such as quantitative measurement of stable-isotope labeled peptides, to clinical translational studies of diagnostic and therapeutic biomarkers for AD. Dr. Bateman trains junior faculty, postdoctoral fellows, graduate students, and undergraduates in his lab and has been the primary mentor for more than twenty junior faculty, clinical fellows, post-doctoral researchers, graduate and medical students who have been successful in their desired medical and scientific careers.

Read More >

Donate to the Bateman Alzheimer’s Research Fund

Make a Donation to the Bateman Lab